Dengvaxia US Pregnancy Registry
Recruiting now
Conditions studied: Dengue Virus Infection
In brief
The primary objective of this study is to assess maternal, obstetrical, pregnancy, and neonatal and infant outcomes among women and their offspring(s) vaccinated with Dengvaxia during their pregnancy
Key facts
- Study ID
- NCT04486638
- Run by
- Sanofi Pasteur, a Sanofi Company
- People needed
- 500
- Starts
- 2023-01-01
- Expected to finish
- 2029-06-30
- Last updated by the study team
- 2026-01-21
Who can join
Age: any. Sex: any. Healthy volunteers: accepted.
Where it is running
- Investigational Site — San Juan, Puerto Rico (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.